Episode Details
Back to Episodes
Episode 59: Ipatercertib in biomarker positive castrate resistant prostate cancer
Published 6 years, 1 month ago
Description
Chris Sweeney (last author) discusses the ATK inhibitor Ipatercertib in pTEN altered CRPC. A positive R3 trial in the ESMO plenary session.